Solid Biosciences SLDB
NASDAQ SLDB
$6.85 -0.13 (-1.86%)
At close: Oct 2, 2026 · 4:00 PM EDT

Solid Biosciences (SLDB) Return on Equity [ROE] (2018 - 2026)

Updated

Solid Biosciences' Return on Equity [ROE] came in at -55.36% for Q2 2026, up 0.39 percentage points from -55.75% a year earlier and up 13.86 percentage points from the prior quarter.

Analysis

Solid Biosciences (SLDB) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Solid Biosciences' Return on Equity [ROE] was -109.90%, down 15.33 percentage points from FY2024.

  • Return on Equity [ROE] has declined in each of the last three years, with a five-year change of -26.66 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Equity [ROE] was -94.57% in FY2024 (-37.78 pp), -56.79% in FY2023 (-15.83 pp), -40.96% in FY2022 (+1.47 pp) and -42.43% in FY2021 (+40.81 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q2 2024.
  • Year-over-year, Return on Equity [ROE] increased in two of the last eight quarters, with an average year-over-year change of -6.76 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2021 (a gain of 281.40 percentage points), and the weakest in Q3 2022 (a drop of 26.06 percentage points).
  • Business Quant data shows SLDB's Return on Equity [ROE] at -69.22% (Q1 2026), -87.61% (Q4 2025) and -70.19% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Solid Biosciences 984.27 Mn 984.27 Mn - -55.36%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -55.36%
Mar 31, 2026 -69.22%
Dec 31, 2025 -87.61%
Sep 30, 2025 -70.19%
Jun 30, 2025 -55.75%
Mar 31, 2025 -64.71%
Dec 31, 2024 -81.97%
Sep 30, 2024 -56.87%
Jun 30, 2024 -44.90%
Mar 31, 2024 -53.53%
Dec 31, 2023 -70.90%
Sep 30, 2023 -58.96%
Jun 30, 2023 -51.95%
Mar 31, 2023 -45.88%
Dec 31, 2022 -48.45%
Sep 30, 2022 -58.55%
Jun 30, 2022 -50.04%
Mar 31, 2022 -40.95%
Dec 31, 2021 -33.45%
Sep 30, 2021 -32.49%
API Access

Solid Biosciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SLDB&period=max&api_key=YOUR_API_KEY